Become a Member

Topic Archives: Max Macaluso

Articles

Comments

  • Avatar
    grief on Nexus-9 Network / Dec 17, 6:06am

    Stansberry research Tim Phaeln at investors alley Contrarian outlook...

    Read More
  • Avatar
    Gerald on Explaining “26(f) Programs” and the “Retirement Blackout” on April 10 teased by Keith Fitz-Gerald / Jan 22, 10:33pm

    I have been disappointed in Fitzg's newsletter. But I have picked up good advice from Tim Plaehn's Investors' Alley. He...

    Read More
  • Avatar
    frankw17 on Sea of Tranquility / Oct 30, 3:20pm

    From Bret Jensen of Investors Alley: Amicus Therapeutics (NASDAQ: FOLD), another attractive small biotech concern se...

    Read More
  • Avatar
    Normally Dubious on “How to get 7% from one of the nation’s best run, least known, specialty banks” / May 17, 4:07am

    Well, thats a switch. Ordinarily I'd say I've gotten some of the worst advice from Investors Alley in the last year....

    Read More
  • Avatar
    bksansoo on Oxford Income Letter, the / Jan 8, 4:56pm

    I still subscribe to The Oxford Income Letter. It's still okay and I do like reading their take on the markets. I am al...

    Read More
  • Avatar
    lynnegaudette on Friday File — Brands, Hospitals and the Yuan / Aug 16, 2:56pm

    Change of subject, I received an email from Investor's Alley saying that 19 major banks to shut down. Do you have any c...

    Read More
  • Avatar
    KennyG on written by reader The Zed Files / Feb 25, 11:36am

    (Do your own Due Diligence: No position in either company - KennyG) 2 Attractive Small-Cap Biotech Stocks On The Verge ...

    Read More
  • DrKSSMDPhD
    DrKSSMDPhD on The Finale is Grand: The Gain from Pain Mainly Explained / Dec 25, 2:01am

    Hi Rae: I happened to be awake because the any-minute coming of Santa Claus excites me. $EW is a classy company whose...

    Read More
  • Avatar
    raehepburn on The Finale is Grand: The Gain from Pain Mainly Explained / Dec 24, 7:30pm

    $EW Dr. KSS what is your opinion of $EW - Edwards Lifesciences. It quietly goes about its business with very little p...

    Read More

    • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info